Prabhat Bhargava

Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study

Vikas Ostwal, Anant Ramaswamy, Prabhat Bhargava et al. · BMJ Open · 2021 · 48 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

COVID‐19 in cancer patients on active systemic therapy – Outcomes from LMIC scenario with an emphasis on need for active treatment

Anant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik et al. · Cancer Medicine · 2020 · 43 citations · Full text

Medicine, Infectious Diseases, Oncology +11

Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial

Jyoti Bajpai, Venkatesh Kapu, Sushmita Rath et al. · The Lancet Oncology · 2024 · 41 citations

Medicine, Pharmacology, Pharmacotherapy +17

Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)

Vikas Ostwal, Sarika Mandavkar, Prabhat Bhargava et al. · Journal of Clinical Oncology · 2023 · 34 citations

Medicine, Oncology, Pharmacology +17

Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer

Anant Ramaswamy, Vikas Ostwal, Atul Sharma et al. · JAMA Oncology · 2020 · 32 citations · Full text

Medicine, Oncology, Pharmacology +16